共 47 条
- [41] Primary tumor sidedness impacts on prognosis and treatment outcome: results from three randomized studies of panitumumab plus chemotherapy versus chemotherapy or chemotherapy plus bevacizumab in 1st and 2nd line RAS/BRAF WT mCRCANNALS OF ONCOLOGY, 2016, 27Boeckx, N.Toler, A.Op de Beeck, K.Kafatos, G.Deschoolmeester, V.Rolfo, C.Lowe, K.Van Camp, G.Demonty, G.Peeters, M.
- [42] Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-AsiaLUNG CANCER, 2024, 197Kato, YukiUdagawa, HibikiMatsumoto, ShingoIzumi, HirokiOhe, YuichiroKato, TerufumiNishino, KazumiMiyamoto, ShingoKawana, SachikoChikamori, KenichiShingyoji, MasatoSato, YukiTakada, YujiToyozawa, RyoAzuma, KoichiTanaka, YuSakai, TetsuyaShibata, YujiSugiyama, EriNosaki, KanameZenke, YoshitakaUmemura, ShigekiYoh, KiyotakaSeike, MasahiroGoto, Koichi
- [43] Patient Reported Outcomes over Time in 25,988 Axial Spondyloarthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Clinical Practice - Is PRO Remission Achieved? Results from the EuroSpA CollaborationARTHRITIS & RHEUMATOLOGY, 2019, 71Ornbjerg, Lykke MidtbollAskling, JohanLoft, Anne GitteNissen, Michael J.Mann, HermanDireskeneli, HanerIannone, FlorenzoSexton, JoeNordstrom, DanSantos, Maria JoseCodreanu, CatalinPombo-Suarez, ManuelRotar, ZigaGudbjornsson, BjornVan der Horst-Bruinsma, IreneLindstrom, UlfCiurea, AdrianPavelka, KarelYilmaz, NeslihanGremese, ElisaKristianslund, EirikHokkanen, Anna MariBarcelos, AnabelaIonescu, RuxandraSanchez-Piedra, CarlosTomsic, MatijaGeirsson, Arni Jonvan de Sande, MarleenMacfarlane, GaryBrahe, Cecilie HeegaardHetland, Merete LundOstergaard, Mikkel
- [44] Treatment of Myeloma Patients Progressing on Lenalidomide-Based Maintenance after ASCT Performed As Part of 1st, 2nd or 3rd Line Therapy: RealWorld Results from the National Myeloma Canada Research Network (MCRN) DatabaseBLOOD, 2019, 134Reece, Donna E.Masih-Khan, EstherAtenafu, Eshetu G.Jimenez-Zepeda, VictorMcCurdy, ArleighSong, KevinLeblanc, RichardSebag, MichaelWhite, Darrell J.Cherniawsky, HannahReiman, TonyStakiw, JulieLouzada, Martha L.Kotb, RamiAslam, MuhammadGul, EnginVenner, Christopher P.
- [45] EXPERIMENTAL STUDIES INTO PMSG TREATMENT OF SOWS IN EARLY-PREGNANCY FOR STIMULATION OF PRENATAL DEVELOPMENT 1ST COMMUNICATION - CLINICAL-RESULTS OBTAINED FROM EMBRYONIC-DEVELOPMENT IN SLAUGHTERED GILTS AND LITTER SIZES OF GILTS AND ADULT SOWS, FOLLOWING PMSG TREATMENT ON 11TH DAY OF PREGNANCYARCHIV FUR EXPERIMENTELLE VETERINARMEDIZIN, 1989, 43 (03): : 351 - 357SPITSCHAK, KHUHN, U
- [46] ADDITION OF BEVACUZIMAB (BEV) TO PEMETREXED (PEM) PLUS CISPLATIN (CIS) INDUCTION AND PEM MAINTENANCE THERAPY IN 1ST LINE SETTING FOR TREATMENT OF ADVANCED NONSQUAMOUS NON SMALL CELL LUNG CANCER (NS-NSCLC) - FINAL RESULTS AND SAFETY UPDATE FROM A PHASE 2 STUDYJOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S860 - S860Hillerdal, GunnarSorensen, Jens B.Hoeffken, GertFavaretto, AdolfoPerez Carrion, RamonVisseren-Grul, CarlaAmeryckx, SophieSoldatenkova, VictoriaBourayou, NawelSantoro, Armando
- [47] Abstracts to the 12th International Congress European Society for Child and Adolescent PsychiatryDevelopmental psychopathology: Transmission and change. Influence of transmission models on understanding development, diagnosis, and treatment of psychiatric disorders of children and adolescents. September 28th—October 1st 2003 C. N. I. T. (Centre National des Industries et Techniques) 2, Place de la Défense 92053 Paris—La Défence, FranceEuropean Child & Adolescent Psychiatry, 2003, 12 (Suppl 2) : ii1 - ii240Ph. Jeammet